Equity Details
Price & Market Data
Price: $9.63
Daily Change: +$0.131 / 1.36%
Daily Range: $9.20 - $9.92
Market Cap: $1,581,894,656
Daily Volume: 6,135,796
Performance Metrics
1 Week: 18.77%
1 Month: 18.62%
3 Months: 9.94%
6 Months: 29.30%
1 Year: 51.74%
YTD: 43.15%
About Novavax, Inc. (NVAX)
Uncover market data for Novavax, Inc. (NVAX). Price: 9.63, daily change: +$0.131 / 1.36%. Market cap: 1,581,894,656. Performance from 1-week to 6-month.
Company Details
Employees: 749
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.